Covid-19 and Influenza Oral Vaccine Study — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Covid-19 and Influenza Oral Vaccine Study — Stella

Home/covid19 Infection/

View on ClinicalTrials.gov

Recruiting

Back to covid19 Infection trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

Australia

ARASMI, Adelaide, South Australia

Key details

Phase

Early testing

Sponsor

Vaxine Pty Ltd

Collaborators

Australian Respiratory and Sleep Medicine Institute Ltd

Enrollment target

~100 participants

Started

May 2024

Primary completion

December 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated September 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.